Real Pharma India Private Limited
About Real Pharma India Private Limited
Data last updated:
Real Pharma India Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Khem Project Investments Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 July 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1996PTC101322. Its GSTIN is 27AAACR3222Q1Z6 (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹36 Lakh. It is led by directors including Anil Prakash and Ananya Anil Prasad Singh.
Its last annual general meeting (AGM) was held on 12 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 708 7 Thfloor Hubtown Viva Western Express Highway Shankarwadi Jogeshwari (East), Mumbai, Maharashtra, India – 400060.
As per the financials filed for FY 2025, the company reported a revenue of ₹56.8 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹24.95 Lakh (net margin 43.9%) and EBITDA of ₹33.9 Lakh (EBITDA margin 59.7%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Real Pharma India Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address708 7 Thfloor Hubtown Viva Western Express Highway Shankarwadi Jogeshwari (East), Mumbai, Maharashtra, India – 400060
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Real Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Real Pharma India Private Limited
FY 2025 filings availableReal Pharma India Private Limited reported revenue of ₹56.8 Lakh (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 2% fall in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33.9 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24.95 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 59.7% | ||||
| Net Profit Margin | 43.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Real Pharma India Private Limited, buy the company report.
Board of directors of Real Pharma India Private Limited
Real Pharma India has 3 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Prakash Also directs: Carbide (Asia) Pvt Ltd, Sal Technologies & Solutions Limited, Midvalley Estates Private Limited and 5 more | Director | 20 Jun 2021 | 5 Years 4 Months | Current |
| Ananya Anil Prasad Singh Also directs: Carbide (Asia) Pvt Ltd, Sal Technologies & Solutions Limited, Midvalley Estates Private Limited and 5 more | Director | 01 Dec 2022 | 3 Years 10 Months | Current |
| Anjali Singh | Director | 17 Jul 2025 | 1 Years 3 Months | Current |
Peer comparison
Real Pharma India Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nexgen Remedies Private Limited | ₹57.57 Lakh (FY 2018) | -47.0% | Patna, Bihar, India | |||
| Pearl Medilife Private Limited | ₹57.5 Lakh (FY 2024) | 7.0% | Ahmedabad, Gujarat, India | |||
| Borra Health Care Private Limited | ₹57.39 Lakh (FY 2023) | 5.0% | Hyderabad, Telangana, India | |||
| Aveza Pharmaceuticals Private Limited | ₹57.37 Lakh (FY 2025) | 34.0% | Jaipur, Rajasthan, India | |||
| Arvoni Lifesciences Private Limited | ₹57.03 Lakh (FY 2025) | -58.0% | Zirakpur, Punjab, India | |||
| Real Pharma India Private Limitedthis company | ₹56.8 Lakh (FY 2025) | ₹24.95 Lakh | 43.9% | -2.0% | Mumbai, Maharashtra, India | |
| Richie Laboratories Limited | ₹56.7 Lakh (FY 2025) | -1.0% | Guwahati, Assam, India | |||
| Pharmika India Private Limited | ₹56.61 Lakh (FY 2024) | -7.0% | Delhi, India | |||
| Scintillam Nutrapeutics Private Limited | ₹56.48 Lakh (FY 2025) | -8.0% | Delhi, India | |||
| Biogreen Remedies Private Limited | ₹56.43 Lakh (FY 2025) | -12.0% | Banjarahills, Telangana, India | |||
| Nimaco Formulations (India) Private Limited | ₹56.37 Lakh (FY 2024) | -77.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Real Pharma India Private Limited, buy the company report.
Auditor
Real Pharma India Private Limited is audited by M G AGRAWAL & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M G AGRAWAL & Associates | FY 2023 | 137845W |
Shareholding
The shareholding of Real Pharma India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Real Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Real Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Real Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Real Pharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACR3222Q1Z6 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Real Pharma India Private Limited, buy the company report.
Recent activity
Real Pharma India Private Limited has 14 board changes on record since 2007: 3 appointments and 11 cessations. The latest: Anjali Singh ceased to be Additional Director on 11 Sep 2025.
5 earlier events are in the company report.
Frequently asked questions
Real Pharma India is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 July 1996 (30+ years old) and is registered under CIN U24230MH1996PTC101322.
Real Pharma India has 3 current directors:
- Anil Prakash - Director
- Ananya Anil Prasad Singh - Director
- Anjali Singh - Director
The latest financial statements of Real Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 12 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Real Pharma India is 27AAACR3222Q1Z6, registered in Maharashtra.
The CIN (Corporate Identification Number) of Real Pharma India is U24230MH1996PTC101322. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Real Pharma India was incorporated on 24 July 1996, making it 30+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Real Pharma India by revenue are Nexgen Remedies Private Limited, Pearl Medilife Private Limited, Borra Health Care Private Limited, Aveza Pharmaceuticals Private Limited, Arvoni Lifesciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Anjali Singh ceased to be Additional Director on 11 Sep 2025. Anjali Singh was appointed as Director on 17 Jul 2025. Ananya Anil Prasad Singh ceased to be Additional Director on 29 Sep 2023. Real Pharma India has 14 board changes on record in total.
The registered office of Real Pharma India is at 708 7 Thfloor Hubtown Viva Western Express Highway Shankarwadi Jogeshwari East, Mumbai, Maharashtra, India – 400060.
Real Pharma India operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Real Pharma India is compliant as of 14 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
